{
  "content": "7.\nJanuary CT , Wann LS , Calkins H , et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.Circulation. 2019;140(2):e125-e151. doi:10.1161/CIR.0000000000000665PubMedGoogle ScholarCrossref\n8.\nHindricks G , Potpara T , Dagres N , et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).Eur Heart J. 2020;2020.PubMedGoogle Scholar\n9.",
  "source": "https://jamanetwork.com/journals/jamacardiology/fullarticle/2779384",
  "chunk_id": "12f78629-81c4-4471-87cb-563f6d6af980",
  "similarity_score": 0.36516493558883667,
  "query": "atrial fibrillation guidelines ESC AHA CCS amiodarone beta-blockers recommendations clinical practice first-line therapy",
  "rank": 23,
  "title": "Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials",
  "authors": "Mohit K. Turagam, Daniel Musikantow, William Whang, Jacob S. Koruth, Marc A. Miller, Marie-Noelle Langan, Aamir Sofi, Subbarao Choudry, Srinivas R. Dukkipati, Vivek Y. Reddy",
  "year": "2021",
  "journal": "JAMA Cardiology",
  "reference": "Turagam, M. K., Musikantow, D., Whang, W., Koruth, J. S., Miller, M. A., Langan, M.-N., Sofi, A., Choudry, S., Dukkipati, S. R., & Reddy, V. Y. (2021). Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: A meta-analysis of randomized clinical trials. JAMA Cardiology, 6(6), 697â€“705. https://doi.org/10.1001/jamacardio.2021.0852",
  "doi": "10.1001/jamacardio.2021.0852",
  "chunk_index": 84,
  "total_chunks": 108,
  "retrieved_at": "2025-07-24T21:58:06.270528"
}